These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

795 related items for PubMed ID: 14660272

  • 1. An independent comparison of terbinafine and itraconazole in the treatment of toenail onychomycosis.
    Cohen AD, Medvesovsky E, Shalev R, Biton A, Chetov T, Naimer S, Shai A, Vardy DA.
    J Dermatolog Treat; 2003 Dec; 14(4):237-42. PubMed ID: 14660272
    [Abstract] [Full Text] [Related]

  • 2. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
    Gupta AK, Konnikov N, Lynde CW.
    J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
    [Abstract] [Full Text] [Related]

  • 3. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.
    Gupta AK, Lynde CW, Konnikov N.
    J Am Acad Dermatol; 2001 Mar; 44(3):485-91. PubMed ID: 11209119
    [Abstract] [Full Text] [Related]

  • 4. An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis.
    Arca E, Taştan HB, Akar A, Kurumlu Z, Gür AR.
    J Dermatolog Treat; 2002 Mar; 13(1):3-9. PubMed ID: 12006131
    [Abstract] [Full Text] [Related]

  • 5. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
    Gupta AK, Gover MD, Lynde CW.
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis.
    Gupta AK, Ryder JE, Johnson AM.
    Br J Dermatol; 2004 Mar; 150(3):537-44. PubMed ID: 15030339
    [Abstract] [Full Text] [Related]

  • 8. Onychomycosis: a new emerging infectious disease in childhood population and adolescents. Report on treatment experience with terbinafine and itraconazole in 36 patients.
    Ginter-Hanselmayer G, Weger W, Smolle J.
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):470-5. PubMed ID: 18194238
    [Abstract] [Full Text] [Related]

  • 9. Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents.
    Piraccini BM, Sisti A, Tosti A.
    J Am Acad Dermatol; 2010 Mar; 62(3):411-4. PubMed ID: 20159308
    [Abstract] [Full Text] [Related]

  • 10. Itraconazole pulse therapy vs continuous terbinafine dosing for toenail onychomycosis.
    Kejda J.
    Postgrad Med; 1999 Jul; Spec No():12-5. PubMed ID: 10492661
    [Abstract] [Full Text] [Related]

  • 11. Two novel itraconazole pulse therapies for onychomycosis: a 2-year follow-up.
    Avner S, Nir N, Baruch K, Henri T.
    J Dermatolog Treat; 2006 Jul; 17(2):117-20. PubMed ID: 16766337
    [Abstract] [Full Text] [Related]

  • 12. Itraconazole pulse therapy in the treatment of disto-lateral subungual onychomycosis.
    Aman S, Akbar TM, Hussain I, Jahangir M, Haroon TS.
    J Coll Physicians Surg Pak; 2003 Nov; 13(11):618-20. PubMed ID: 14700485
    [Abstract] [Full Text] [Related]

  • 13. The use of an intermittent terbinafine regimen for the treatment of dermatophyte toenail onychomycosis.
    Gupta AK, Lynch LE, Kogan N, Cooper EA.
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):256-62. PubMed ID: 19438818
    [Abstract] [Full Text] [Related]

  • 14. Prognostic factors for cure following treatment of onychomycosis.
    Sigurgeirsson B.
    J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):679-84. PubMed ID: 19929941
    [Abstract] [Full Text] [Related]

  • 15. Intermittent versus continuous terbinafine in the treatment of toenail onychomycosis: a randomized, double-blind comparison.
    Sigurgeirsson B, Elewski BE, Rich PA, Opper C, Cai B, Nyirady J, Bakshi R.
    J Dermatolog Treat; 2006 Jun; 17(1):38-44. PubMed ID: 16467022
    [Abstract] [Full Text] [Related]

  • 16. Safety and efficacy of oral terbinafine in the treatment of onychomycosis: analysis of the elderly subgroup in Improving Results in ONychomycosis-Concomitant Lamisil and Debridement (IRON-CLAD), an open-label, randomized trial.
    Tavakkol A, Fellman S, Kianifard F.
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):1-13. PubMed ID: 16730616
    [Abstract] [Full Text] [Related]

  • 17. A pilot evaluation of pulse itraconazole vs. terbinafine for treatment of Candida toenail onychomycosis.
    Warshaw EM, Nelson D, Carver SM, Zielke GR, Webster N, Lederle FA, Fett DD.
    Int J Dermatol; 2005 Sep; 44(9):785-8. PubMed ID: 16135154
    [No Abstract] [Full Text] [Related]

  • 18. A cost/efficacy analysis of oral antifungals indicated for the treatment of onychomycosis: griseofulvin, itraconazole, and terbinafine.
    Angello JT, Voytovich RM, Jan SA.
    Am J Manag Care; 1997 Mar; 3(3):443-50. PubMed ID: 10173095
    [Abstract] [Full Text] [Related]

  • 19. Clinical and histological aspects of toenail onychomycosis caused by Aspergillus spp.: 34 cases treated with weekly intermittent terbinafine.
    Gianni C, Romano C.
    Dermatology; 2004 Mar; 209(2):104-10. PubMed ID: 15316163
    [Abstract] [Full Text] [Related]

  • 20. A double-blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe-nail onychomycosis.
    Havu V, Brandt H, Heikkilä H, Hollmen A, Oksman R, Rantanen T, Saari S, Stubb S, Turjanmaa K, Piepponen T.
    Br J Dermatol; 1997 Feb; 136(2):230-4. PubMed ID: 9068738
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.